Chairman and CEO of Abbott Laboratories, Ford is a transformative leader advancing healthcare diagnostics, nutrition, and medical technologies.
What are Robert Ford's top stock holdings?
Explore Robert Ford's largest investments on Profit.com, including companies like Abbott Laboratories, and their significance in his portfolio.
How often does Robert Ford update their portfolio?
Robert Ford’s portfolio updates are typically published quarterly through SEC 13F filings, which provide detailed information about their holdings, including recent buys and sells. Additionally, real-time updates on insider trades are available through Form 4 filings, offering a more timely view of their trading activity.
What companies does Robert Ford invest in?
Robert Ford currently invests in companies such as Abbott Laboratories, focusing on sectors like Healthcare.
What is the largest holding in Robert Ford’s portfolio?
The largest holding in Robert Ford’s portfolio is Abbott Laboratories, accounting for 100.00% of their total investments.
What is Robert Ford’s most profitable investment?
One of Robert Ford’s most profitable investments is Abbott Laboratories, which has generated a return of -9.14% over the past year.
How much is Robert Ford’s portfolio worth?
As of 06 Nov 2026, Robert Ford’s portfolio is valued at approximately $59.41M, based on the latest filings available on Profit.com.
Can I follow Robert Ford’s investments to build my own portfolio?
Yes, you can use Profit.com to follow Robert Ford’s portfolio and gain insights to build your own investment portfolio.
How can I follow Robert Ford’s portfolio updates?
You can follow Robert Ford’s portfolio updates on Profit.com, which provides notifications on the latest portfolio transactions as soon as they’re available.
How can I stay updated on Robert Ford’s trades?
Stay up-to-date with Robert Ford’s latest trades by following their portfolio on Profit.com. Enable notifications to receive real-time alerts on their newest buy and sell transactions.
SEC Filings
Form
Name
Filing Date
Report Date
4
Statement of changes in beneficial ownership of securities - general instructions
27 Aug 2026
25 Aug 2026
144
Notice of proposed sale of securities pursuant to Rule 144
25 Aug 2026
-
4
Statement of changes in beneficial ownership of securities - general instructions
03 Mar 2026
27 Feb 2026
4
Statement of changes in beneficial ownership of securities - general instructions
26 Feb 2026
24 Feb 2026
4
Statement of changes in beneficial ownership of securities - general instructions
26 Jan 2026
23 Jan 2026
4
Statement of changes in beneficial ownership of securities - general instructions
04 Mar 2025
28 Feb 2025
4
Statement of changes in beneficial ownership of securities - general instructions
27 Feb 2025
25 Feb 2025
4
Statement of changes in beneficial ownership of securities - general instructions
07 Feb 2025
05 Feb 2025
144
Notice of proposed sale of securities pursuant to Rule 144
05 Feb 2025
-
4
Statement of changes in beneficial ownership of securities - general instructions
13 Sep 2024
12 Sep 2024
144
Notice of proposed sale of securities pursuant to Rule 144
12 Sep 2024
-
4
Statement of changes in beneficial ownership of securities - general instructions
04 Mar 2024
29 Feb 2024
4
Statement of changes in beneficial ownership of securities - general instructions
23 Feb 2024
21 Feb 2024
4
Statement of changes in beneficial ownership of securities - general instructions
02 Mar 2023
28 Feb 2023
4
Statement of changes in beneficial ownership of securities - general instructions
22 Feb 2023
17 Feb 2023
4
Statement of changes in beneficial ownership of securities - general instructions
26 Aug 2022
25 Aug 2022
4
Statement of changes in beneficial ownership of securities - general instructions
01 Apr 2022
25 Mar 2022
4
Statement of changes in beneficial ownership of securities - general instructions
02 Mar 2022
28 Feb 2022
4
Statement of changes in beneficial ownership of securities - general instructions
23 Feb 2022
18 Feb 2022
4
Statement of changes in beneficial ownership of securities - general instructions
02 Jul 2021
25 Jun 2021
4
Statement of changes in beneficial ownership of securities - general instructions
02 Mar 2021
26 Feb 2021
4
Statement of changes in beneficial ownership of securities - general instructions